Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
作者:Alessandro Deplano、Mariateresa Cipriano、Federica Moraca、Ettore Novellino、Bruno Catalanotti、Christopher J. Fowler、Valentina Onnis
DOI:10.1080/14756366.2018.1532418
日期:2019.1.1
Abstract Fatty Acid Amide Hydrolase (FAAH) is a serine hydrolase that plays a key role in controlling endogenous levels of endocannabinoids. FAAH inhibition is considered a powerful approach to enhance the endocannabinoid signalling, and therefore it has been largely studied as a potential target for the treatment of neurological disorders such as anxiety or depression, or of inflammatory processes
抽象的 脂肪酸酰胺水解酶(FAAH)是一种丝氨酸水解酶,在控制内源性内源性大麻素中起关键作用。FAAH抑制被认为是增强内源性大麻素信号传导的有效方法,因此,已广泛研究了FAAH抑制作为治疗神经系统疾病(如焦虑症或抑郁症或炎症过程)的潜在靶标的方法。我们提出了两个新的布洛芬酰胺衍生物系列,它们被设计为我们的参考FAAH抑制剂Ibu-AM5的类似物,以进一步探索其结构活性关系。在新的酰胺中,Ibu-AM5的2-甲基吡啶部分被苄基氨基和哌嗪子基芳基部分取代。所获得的苄基酰胺和哌嗪基芳基酰胺显示出从低到高的微摩尔效价的FAAH抑制。